Showing results (61-70 of 90) with videos related to
Sort By:
Pageof 9
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1997
In vivo hybridization of technetium-99m-labeled peptide nucleic acid (PNA)G Mardirossian, K Lei, M Rusckowski, et al.European Journal of Nuclear Medicine|January 1, 1987
Characterization of indium-111 labeled recombinant tissue plasminogen activator for the imaging of thrombiD J Hnatowich, F Virzi, P W Doherty, et al.The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 23, 2002
The influence of chain length and base sequence on the pharmacokinetic behavior of 99mTc-morpholinos in miceG Liu, S Zhang, J He, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2001
In vitro investigations of tumor targeting with (99m)Tc-labeled antisense DNAY M Zhang, Y Wang, N Liu, et al.Nuclear Medicine and Biology|August 24, 2001
A novel and simplified route to the synthesis of N3S chelators for 99mTc labelingZ Zhu, Y Wang, Y Zhang, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 1998
Labeling peptides with technetium-99m using a bifunctional chelator of a N-hydroxysuccinimide ester of mercaptoacetyltriglycineD J Hnatowich, T Qu, F Chang, et al.Nuclear Medicine and Biology|June 25, 1998
Human polyclonal immunoglobulin labelled with technetium-99m via NHS-MAG3: a comparison of radiochemical behavior and biological efficacy with other labelling methodsL Gano, L Patrício, E Marques, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1982
Evaluation of the viability of In-111-labeled DTPA coupled to fibrinogenW W Layne, D J Hnatowich, P W Doherty, et al.The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 20, 2010
Tumor pretargeting in mice using MORF conjugated CC49 antibody and radiolabeled complimentary cMORF effectorG Liu, S Dou, P H Pretorius, et al.Bioconjugate Chemistry|September 20, 2001
Pretargeting with amplification using polymeric peptide nucleic acidY Wang, F Chang, Y Zhang, et al.Pageof 9